Print

Ilypsa, Inc. Announces Appointment Of William D. Waddill As Chief Financial Officer  
10/26/2006 10:39:42 AM

Ilypsa, Inc., a privately-held biopharmaceutical company pioneering novel non-absorbed drugs for renal and metabolic disorders, today announced the appointment of William D. Waddill as Chief Financial Officer.
//-->